Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma
Authors:
- 1 March 2017
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 38 (3) , 1724-1732
Abstract
Esophageal cancer ranks as the sixth leading cause of cancer-related deaths worldwide. Cancer stemness is mainly considered to be the key factor for cancer recurrence particularly in esophageal cancer. It is important to identify cancer stem cell markers as targets in future therapies. The present study aimed to investigate the expression of putative cancer stem cell-related marker musashi1 (Msi1) and assess the correlation with clinicopathologcal status of esophageal squamous cell carcinoma (ESCC) cases. We then clarified the role of Msi1 in esophageal cancer cells during proliferation, apoptosis, sphere formation and migration. Finally, we investigated the relationship of Msi1 with the prognosis of ESCC patients. ESCC tissue samples from 93 patients and 20 paired histologically normal tissues were procured for immunohistochemical analysis. We analyzed the characteristics of Msi1, using sphere formation and anchorage independent growth. Moreover, using flow cytometry and Cell Counting Kit-8 (CCK-8) assay, we investigated the role of Msi1 in cancer cell proliferation and apoptosis. Furthermore, we clarified the role of Msi1 in the process of sphere formation and migration of ESCC cells through knockdown of Msi1 expression by siRNA in ESCC cell lines. The results revealed that there was a higher expression of Msi1 in ESCC specimens compared with normal tissues. In addition, Msi1 expression was significantly associated with clinical stage and lymph node metastasis. Most importantly, the increased immunocytochemical staining of Msi1 in spheroid cells revealed the stemness characteristics of Msi1 in ESCC. In addition, we found that silencing of Msi1 decreased cell proliferation, migration and induced apoptosis in TE-7 and KYSE70 cells. Furthermore, downregulation of Msi1 attenuated the sphere formation ability of ESCC cells. Patients with higher expression of Msi1 had a shorter survival. In conclusion, Msi1 acts as a stemness-associated gene in esophageal cancer cell lines and could serve as a prognostic marker in patients with ESCC.Keywords
This publication has 36 references indexed in Scilit:
- Musashi-1 regulates AKT-derived IL-6 autocrinal/paracrinal malignancy and chemoresistance in glioblastomaOncotarget, 2016
- Image-based detection and targeting of therapy resistance in pancreatic adenocarcinomaNature, 2016
- Musashi1 as a potential therapeutic target and diagnostic marker for lung cancerOncotarget, 2013
- A CD90+ Tumor-Initiating Cell Population with an Aggressive Signature and Metastatic Capacity in Esophageal CancerCancer Research, 2013
- The Spatial Distribution of LGR5+ Cells Correlates With Gastric Cancer ProgressionPLOS ONE, 2012
- Identification of musashi-1 and ALDH1 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinomaCancer Biomarkers, 2011
- Identification of Pancreatic Cancer Stem CellsCancer Research, 2007
- Isolation and In vitro Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell PropertiesCancer Research, 2005
- Function of RNA-binding protein Musashi-1 in stem cellsExperimental Cell Research, 2005
- Nuclear expression of p53, p21 and cyclin D1 is increased in bronchioloalveolar carcinomaHistopathology, 1999